+948.4%
MRNA vs FN
+483.6%
+464.8%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | FN | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -8.6% | +6.4% | -0.9% |
| 7D | -12.7% | -13.1% | +0.4% | -10.9% |
| 30D | -20.7% | -19.9% | -0.7% | -18.3% |
| 3M | +46.3% | -35.9% | +82.2% | +54.4% |
| 6M | +305.2% | -57.0% | +362.2% | +348.1% |
| YTD | +561.2% | -37.4% | +598.6% | +562.5% |
| 1Y | +772.1% | -26.4% | +798.5% | +744.6% |
| 3Y | +147.0% | +66.5% | +80.4% | +93.5% |
| 5Y | -26.1% | +146.6% | -172.7% | -47.6% |
| All | +948.4% | +483.6% | +464.8% | +563.9% |
Cumulative growth
Daily Returns
Daily percentage return beside FN.
Daily Out/Under-Performance
Portfolio return minus FN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × FN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded FN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling